Lack of lasting effectiveness of PEG 3350 laxative treatment of constipation

Journal of Clinical Gastroenterology

Volumn 39, Issue 7, 2005, Pages 600-602

  Tran, Lily C ^a   Di Palma, Jack A ^a,b  

^a UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF SOUTH ALABAMA   (United States)

Author keywords

Constipation; Laxative; Polyethylene glycol

Indexed keywords

LAXATIVE; MACROGOL; MACROGOL 3350;

ADULT; ARTICLE; CLINICAL ARTICLE; CONSTIPATION; DRUG EFFICACY; DRUG MONITORING; DRUG SAFETY; EXPERIENCE; FEMALE; HUMAN; INTESTINE MOTILITY; MALE; PRIORITY JOURNAL; SATISFACTION; TREATMENT FAILURE; TREATMENT OUTCOME;

CONSTIPATION; DEFECATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; OBSERVATION; POLYETHYLENE GLYCOLS; TIME FACTORS; TREATMENT FAILURE;

EID: 23044437214     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mcg.0000170769.67320.47     Document Type: Article

References (19)

1. Talley NJ. Management of chronic constipation. Rev Gastroenterol Disord. 2004;4:18-24.
2. American Gastroenterological Association Medical Position Statement. Guidelines on Constipation. Gastroenterology. 2000;119:1761-1778.
3. Jones MP, Talley NJ, Nuyts G, et al. Lack of objective evidence of efficacy of laxatives in chronic constipation. Dig Dis Sci. 2002;47:2222-2230.
4. Di Palma JA. Current treatment options for chronic constipation. Rev Gastroenterol Disord. 2004;4(suppl):34-42.
5. Di Palma JA, DeRidder PH, Orlando RC, et al. A randomized, placebo-controlled, multicenter study of the safety and efficacy of a new polyethylene glycol laxative. Am J Gastroenterol. 2000;95:446-450.
6. Chaussade S, Minic M. Comparison of efficacy and safety of two doses of two different polyethylene glycol-based laxatives in the treatment of constipation. Aliment Pharmacol Ther. 2003;17:165-172.
7. Di Palma JA, MacRae DH, Reichelderfer M, et al. Braintree polyethylene glycol (PEG) laxative for amulatory and long-term care facility constipation patients: report of randomized, cross-over trials. Online Journal of Digestive Health, April 1999, at http://www.ojdh.org.
8. Cleveland vB M, Cleveland B, Flavin DP, Ruben RA, et al. New polyethylene glycol laxative for treatment of constipation in adults: a randomized, double-blind, placebo-controlled study. South Med J. 2001;94:478-481.
9. Di Palma JA, Smith JR, Cleveland VBM. Overnight efficacy of polyethylene glycol laxative. Am J Gastroenterol. 2002;97:1776-1779.
10. Drossman DA, Corazziari E, Talley NJ, et al. Rome II: a multinational consensus document on functional gastrointestinal disorders. Gut. 1999;2 (suppl II):1-81.
11. Stoltz R, Weiss M, Merkin DH, et al. An efficacy and consumer preference study of polyethylene glycol 3350 for the treatment of constipation in regular laxative users. Home Health Care Consultant. 2001;8:21-26.
12. Lasch HM. A new weapon for the arsenal in the war against constipation? Am J Gastroenterol. 2000;95:341-342.
13. Di Palma AM, Di Palma JA. New perspectives on constipation: a clinician's viewpoint [Pharmacology Update]. Practical Gastroenterol. 1999;23:20-41.
14. Gremse DA, Hixon J. Comparison of polyethylene glycol 3350, NF powder and lactulose for treatment of chronic constipation in children [Abstract]. J Pediatr Gastroenterol Nutr. 2000;31:131.
15. Di Palma AM, Di Palma JA. Polyethylene glycol laxative: a new option for constipation. Today's Therapeutic Trends. 2002;20:59-67.
16. Youssef NN, Peters JM, Henderson W, et al. Dose response of PEG 3350 for the treatment of childhood fecal impaction. J Pediatr. 2002;141:410-415.
17. Nurko S. Advances in the management of pediatric constipation. Curr Gastroenterol Rep. 2000;2:234-240.
18. Pashankar D, Bishop WP. Efficacy and optimal dose of polyethylene glycol 3350 (PEG) for treatment of chronic constipation and encopresis in children. Gastroenterology. 2001;120:A754.
19. Loening-Baucke VA. Polyethylene glycol without electrolytes for children with constipation and encopresis. Gastroenterology. 2001;120:A642.